Tailwind Capital has hired Eran Broshy and Cliff Gookin as operating executives. Previously, Broshy was CEO and chairman of inVentiv Health Inc while Gookin was vice president of business development at Omnicare.
NEW YORK (BUSINESS WIRE)–Tailwind Capital, a leading middle market private equity firm investing in growth-oriented companies in targeted sectors in healthcare, business and communications services, announced that it has recently added Eran Broshy and Cliff Gookin as Operating Executives.
Mr. Broshy has over 30 years of management experience within the healthcare industry. Previously, Mr. Broshy served for over a decade as Chief Executive Officer and Chairman of inVentiv Health, Inc., transforming the company into the leading provider of clinical and commercialization services to the global pharmaceutical and biotechnology industries. Prior to his time at inVentiv, Mr. Broshy spent 14 years at The Boston Consulting Group, where he was responsible for the firm’s healthcare practice across the Americas.
Mr. Gookin has over 30 years of M&A, strategic advisory and direct investment experience. Previously, Mr. Gookin served as a Vice President of Business Development at Omnicare (NYSE:OCR), where he was responsible for multiple acquisitions, which added significant revenue and expanded the company into the specialty pharmacy market. Mr. Gookin began his career in investment banking, working at The First Boston Corporation, Bear Stearns & Co. and Rauscher Pierce Refsnes.
Larry Sorrel, Managing Partner at Tailwind, said, “Tailwind has been active in the healthcare sector since the firm’s founding, having invested in many high-quality companies across the healthcare spectrum. We are excited to further strengthen our healthcare expertise with the addition of Eran Broshy and Cliff Gookin as Operating Executives. Both Eran and Cliff have extensive experience in the healthcare industry and we look forward to leveraging this expertise across both our existing portfolio and new investment opportunities.”
Since its founding in 2003, Tailwind has been focused on targeted sectors within the healthcare space. Tailwind’s current investments in the healthcare sector include: Cumberland, a healthcare IT consulting firm; Diamondback Drugs, a veterinary pharmacy; Long’s Drugs, a specialized pharmacy services provider; and National HME, a provider of outsourced medical equipment management solutions to the hospice market. Representative previous investments in the sector include: Aircast, a manufacturer of orthopedic bracing devices; Freedom Innovations, a manufacturer of lower-limb prosthetic devices; SDI Health, a provider of data integration, custom analytics and reporting to the healthcare industry; Trover Solutions, a provider of outsourced insurance subrogation, claims recovery and cost containment services; and Versapharm, a generic pharmaceuticals company.
About Tailwind Capital:
Tailwind Capital is a leading private equity firm focused on growth-oriented investments in the lower end of the middle market in targeted sectors within the healthcare, business and communications services industries in North America. Tailwind partners with experienced management teams and entrepreneurs to transform businesses through organic growth initiatives, acquisitions, and operational and strategic improvements. Since its founding in 2003, Tailwind and its portfolio companies have completed more than 65 acquisitions. The firm currently manages over $2 billion of committed equity capital.